ProMetic BioTherapeutics, Inc. and Blue Blood of Taiwan Form Strategic Alliance to Develop Plasma-Derived Drugs for Taiwan and Southeast Asian Markets

MARYLAND, UNITED STATES, MONTREAL, CANADA and TAIPEI, TAIWAN--(MARKET WIRE)--Jun 11, 2007 -- ProMetic BioTherapeutics, Inc., a subsidiary of ProMetic Life Sciences Inc. (Toronto:PLI.TO - News) ("ProMetic"), and Blue Blood Biotech Corporation ("Blue Blood") have formed a strategic alliance to develop drugs derived from human plasma utilizing ProMetic's proprietary manufacturing process.